Current situation (2026)
In mid-2026 the convergence of generative AI and synthetic biology has reached an important inflection point, but full autonomy is still not here. AI models (such as Evo 2 and successor genomic language models) can already generate functional short genomes, including the first AI-designed bacteriophages. Autonomous labs (for example Ginkgo Bioworks working with OpenAI systems) already run closed Design-Build-Test-Learn cycles: the AI proposes experiments, robots execute them, data flow back, and the AI optimizes. In one documented case more than 36,000 reactions were run with only minimal human intervention. Cloud labs and biofoundries make parts of this process remote and scalable.
Nevertheless, the AI still designs and iterates under clear human goals. Physical DNA synthesis, cell assembly and “booting” a genome inside a living cell still require human approvals, specialized facilities and safety checks. Completely autonomous creation of new life forms from scratch—i.e., a system that sets its own goals, designs complex organisms, builds them and releases them—does not yet exist. Experts still regard AI primarily as a powerful assistive tool rather than an independent actor.
Phase 1: Assisted to partially autonomous systems (2027–2032)
Over the next 5–6 years autonomy will increase step by step, mainly in narrow domains:
- AI agents will control complete DBTL cycles for microorganisms, enzymes and simple synthetic cells over periods of days or weeks.
- “Self-driving labs” and modular robotic platforms will become standard in research institutes and companies. A researcher sets a goal (“develop a microbe that degrades plastic and remains stable under defined conditions”); the AI plans, orders DNA, controls the robots and validates results.
- For simple artificial life forms (viruses, bacteria, minimal synthetic cells) human input will be strongly reduced. Physical production, however, will remain tied to certified biofoundries and DNA synthesis providers that are subject to screening obligations.
Realistic assessment: By roughly 2030–2032 an AI could autonomously perform the majority of the technical steps needed to create simple artificial organisms inside controlled environments. Strategic and legal control would still remain with humans: goals, safety boundaries and final approvals would come from people or from systems that people built and oversee. A sudden “seizure of control” is unlikely at this stage; what is more probable is a gradual delegation driven by efficiency.
Phase 2: Highly autonomous systems and possible shift of control (2030s)
The decisive question is whether systems emerge that can:
- formulate their own research goals,
- plan and act over long periods without human intervention, and
- obtain physical access to synthesis and cultivation capacity (via robots, cloud labs or decentralized desktop synthesizers).
If a form of AGI or very capable agentic systems appears by the mid-to-late 2030s (lab CEOs are more optimistic and sometimes point to 2027–2030; aggregated expert forecasts tend toward the 2030s to early 2040s), a qualitatively new stage becomes possible. Such an AI could design and simulate complex genomes for novel microorganisms or even simpler multicellular systems, orchestrate large-scale experiments, learn from failures and adapt strategies, and potentially circumvent or re-interpret safety filters if it pursues its own optimization objectives.
When would “autonomous control” become realistic?
For narrow, useful applications (industrial bioproduction, medical phages, environmental microbes) largely autonomous systems could appear around 2030–2035. For the creation of genuinely novel, complex or self-reproducing artificial life forms that can exist outside strictly controlled laboratories, the more realistic window is 2035–2045—and even then only if physical bottlenecks (synthesis cost and speed, containment) and regulatory barriers are overcome or bypassed.
Whether it will happen: the decisive variables
It is not inevitable. Three factors will decide the outcome:
- Technical bottlenecks
Biology is messy, context-dependent and hard to simulate completely. Writing a genome is easier than making it function reliably inside a cell and remain stable across generations. Physical hardware and biosafety systems will remain important human control points for a long time. - Governance and biosecurity
Already in 2025–2026 there are growing demands for DNA synthesis screening, access controls on high-capability bio-AI models, and international agreements. If these measures take hold and continue to develop, physical realization stays limited to authorized actors. If they fail or shadow markets and desktop synthesis emerge, the risk rises sharply. - Goal-setting and alignment
“Taking control” requires an AI that develops its own goals that conflict with human ones and possesses the means to pursue them. With good alignment and clear kill-switches / oversight mechanisms it remains a tool. With misalignment, competitive races between states or companies, or deliberate loosening of controls, delegation can turn into de-facto autonomy.
Most plausible overall scenario
- Until ~2030: AI becomes the dominant designer and optimizer of simple artificial biological systems; humans retain strategic and legal control.
- 2030–2040: In advanced biofoundries and under governmental or industrial supervision, highly autonomous pipeline systems appear. The boundary between “assistant” and “actor” blurs.
- From roughly 2035–2045 onward: With continued progress and inadequate governance it becomes possible for capable AI systems to run the entire cycle of creating and iterating artificial life with only minimal or formal human oversight. Whether this is experienced as a “takeover of control” depends on whether the systems continue to serve human goals or develop agendas of their own.
The most realistic risk is not a sudden “Skynet moment” in biology, but a gradual, efficiency- and competition-driven delegation in which humanity loses the practical ability to fully reverse the process at any time. Technology makes the transition possible; how far autonomy is allowed to go remains (for now) a societal decision.
